Phathom Pharmaceuticals, Inc. - PHAT

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$829.1M

QoQ value delta ($000)

-$212.1M (-20.37%)

Implied price effect (QoQ)

-31.57%

Total shares

73,202,427

QoQ shares delta

+10,296,397 (+16.37%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 176 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Frazier Life Sciences Management, L.P.	138,502	12,466,489	3.56%
Medicxi Ventures Management (Jersey) Ltd	82,931	7,464,572	8.45%
VANGUARD GROUP INC	52,709	3,177,211	0.0%
Invesco Ltd.	48,018	4,322,060	0.01%
BlackRock, Inc.	45,128	4,061,996	0.0%
MILLENNIUM MANAGEMENT LLC	44,694	4,022,909	0.02%
Carlyle Group Inc.	38,849	3,496,808	0.37%
VANGUARD CAPITAL MANAGEMENT LLC	28,704	2,583,636	0.0%
NEA Management Company, LLC	21,777	1,960,169	1.24%
683 Capital Management, LLC	20,553	1,850,000	1.07%
Ensign Peak Advisors, Inc	18,084	1,627,806	0.03%
Catalys Pacific, LLC	16,596	1,493,854	7.19%
GW&K Investment Management, LLC	15,789	1,421,109	0.14%
STATE STREET CORP	15,408	1,386,890	0.0%
WASATCH ADVISORS LP	14,897	1,340,916	0.1%
GEODE CAPITAL MANAGEMENT, LLC	14,756	1,328,045	0.0%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	13,392	1,205,369	0.02%
SummitTX Capital, L.P.	11,064	995,885	0.35%
FRANKLIN RESOURCES INC	11,048	994,504	0.0%
PERCEPTIVE ADVISORS LLC	10,276	925,000	0.2%
CITADEL ADVISORS LLC	10,200	918,158	0.0%
MARSHALL WACE, LLP	9,562	860,692	0.01%
Propel Bio Management, LLC	9,354	841,272	5.9%
VANGUARD PORTFOLIO MANAGEMENT LLC	7,399	666,029	0.0%
GOLDMAN SACHS GROUP INC	6,957	626,196	0.0%